Roche's Sabry retires; Duchenne drug fails confirmatory test
BioPharma
Source: biopharmadive.com
📰 Boris Za News
Boris Za News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Boris Za. Real-time updates on events, politics, business and more.
Changes to the Roche Enlarged Corporate Executive Committee
Basel, 27 May 2024 - Roche announced today that James Sabry , Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry joined Genentech in 2010 as Head...
Source: marketscreener.com
F. Hoffmann-La Roche Ltd: Changes to the Roche Enlarged Corporate Executive Committee
Basel, 27 May 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that James Sabry (1958), Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry
Source: finanznachrichten.de
Roche Announces Management and Board Committee Changes
Roche announced that James Sabry , Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry joined Genentech in 2010 as Head of Genentech Partnering. In...
Thomas Schinecker James Sabry Ecole Polytechnique Boris Za Head Of Group Business Development Head Of Corporate Business Development
Source: marketscreener.com